13F-HR filed by MONTANOVA CAPITAL, LLC
MONTANOVA CAPITAL, LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 87 holding rows worth $3,273,687,000.
- Accession
- 0001172661-22-001372
- Filer
- CIK 1569064
- Filed
- 2022-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 87 entries on the cover page, a total value of $3,273,687,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,273,687,000 with VALUE read as thousands by filing date, 13F file number 028-15929. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Microsoft Corp | 594918104 | COM | 595,747 | $183,675,000 | thousands by filing date | |
| Union Pacific Corporation | 907818108 | COM | 613,628 | $167,649,000 | thousands by filing date | |
| Amazon.com, Inc | 023135106 | COM | 45,122 | $147,095,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 240,997 | $122,901,000 | thousands by filing date | |
| LAUDER ESTEE COS INC CL A | 518439104 | Stock | 372,475 | $101,432,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 1,197,206 | $100,793,000 | thousands by filing date | |
| OTIS WORLDWIDE CORP COM | 68902V107 | Stock | 1,297,480 | $99,841,000 | thousands by filing date | |
| Visa Inc | 92826C839 | COM | 437,990 | $97,133,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 1,531,923 | $93,738,000 | thousands by filing date | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 386,710 | $89,411,000 | thousands by filing date | |
| LAS VEGAS SANDS CORP COM | 517834107 | Stock | 2,275,282 | $88,440,000 | thousands by filing date | |
| TAPESTRY INC COM | 876030107 | Stock | 2,320,100 | $86,192,000 | thousands by filing date | |
| S&P Global,Inc. | 78409V104 | COM | 206,760 | $84,809,000 | thousands by filing date | |
| Charles Schwab Corp | 808513105 | COM | 982,790 | $82,859,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 188,888 | $82,198,000 | thousands by filing date | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 2,025,610 | $78,918,000 | thousands by filing date | |
| GFL ENVIRONMENTAL INC SUB VTG SHS | 36168Q104 | Stock | 2,284,496 | $74,337,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 415,310 | $73,605,000 | thousands by filing date | |
| MasterCard, Inc | 57636Q104 | COM | 190,943 | $68,239,000 | thousands by filing date | |
| Danaher Corporation | 235851102 | COM | 232,570 | $68,220,000 | thousands by filing date | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 115,069 | $67,966,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 3,893,019 | $62,600,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 2,613,412 | $61,807,000 | thousands by filing date | |
| RH | 74967X103 | COM | 181,835 | $59,295,000 | thousands by filing date | |
| CENCORA INC COM | 03073E105 | Stock | 383,138 | $59,275,000 | thousands by filing date | |
| HILTON WORLDWIDE HLDGS INC COM | 43300A203 | Stock | 362,703 | $55,037,000 | thousands by filing date | |
| MARRIOTT INTL INC NEW CL A | 571903202 | Stock | 309,240 | $54,349,000 | thousands by filing date | |
| Energy Select Sector SPDR Fund | 81369Y506 | SHS | 692,868 | $52,963,000 | thousands by filing date | |
| BATH & BODY WORKS INC COM | 070830104 | Stock | 1,038,630 | $49,647,000 | thousands by filing date | |
| MARQETA INC | 57142B104 | CLASS A COM | 4,049,950 | $44,711,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 510,331 | $41,959,000 | thousands by filing date | |
| DECKERS OUTDOOR CORP | 243537107 | COM | 142,477 | $39,006,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 525,100 | $38,133,000 | thousands by filing date | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 2,909,407 | $35,349,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 1,177,374 | $34,273,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,318,432 | $30,983,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 3,732,400 | $30,680,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 97,980 | $29,995,000 | thousands by filing date | |
| WYNN RESORTS LTD | 983134107 | COM | 366,060 | $29,190,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 2,766,000 | $25,862,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,746,300 | $25,740,000 | thousands by filing date | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 3,014,408 | $24,025,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 584,660 | $23,784,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 1,434,200 | $23,464,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 1,409,956 | $23,433,000 | thousands by filing date | |
| CANO HEALTH INC | 13781Y103 | COM | 3,668,478 | $23,295,000 | thousands by filing date | |
| SPDR SER TR | 78468R556 | S&P OILGAS EXP | 164,970 | $22,197,000 | thousands by filing date | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 1,533,059 | $21,493,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 692,000 | $21,154,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 2,869,048 | $16,411,000 | thousands by filing date | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 827,540 | $15,007,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 2,766,619 | $12,671,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 9,142,067 | $10,239,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 4,059,894 | $9,338,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 7,224,860 | $8,670,000 | thousands by filing date | |
| MOLECULAR PARTNERS AG | 60853G106 | ADS | 400,000 | $8,220,000 | thousands by filing date | |
| OTONOMY INC | 68906L105 | COM | 3,144,196 | $7,546,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 61,631 | $7,308,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 406,200 | $6,763,000 | thousands by filing date | |
| AMBRX BIOPHARMA, INC. SPONSORED ADR | 02290A102 | COM | 1,491,832 | $6,146,000 | thousands by filing date | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 2,230,250 | $6,111,000 | thousands by filing date | |
| Inflarx Nv | N44821101 | COM | 3,285,000 | $6,012,000 | thousands by filing date | |
| RESEARCH ALLIANCE CORP II | 760873109 | CMN | 500,000 | $4,885,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 344,755 | $4,268,000 | thousands by filing date | |
| INOZYME PHARMA INC | 45790W108 | COM | 1,013,216 | $4,144,000 | thousands by filing date | |
| SIO GENE THERAPIES INC | 829399104 | COM | 5,914,000 | $3,962,000 | thousands by filing date | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 1,238,800 | $3,679,000 | thousands by filing date | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 681,528 | $3,367,000 | thousands by filing date | |
| GEMINI THERAPEUTICS INC | 36870G105 | CMN | 2,372,267 | $3,297,000 | thousands by filing date | |
| OMEGA ALPHA SPAC | G6749V107 | CL A | 300,000 | $2,946,000 | thousands by filing date | |
| EUROPEAN BIOTECH ACQUTN CORP | G3167F102 | CLASS A ORD SHS | 300,000 | $2,922,000 | thousands by filing date | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 440,696 | $2,353,000 | thousands by filing date | |
| OPY ACQUISITION CORP I | 671005205 | UNIT 09/22/2026 | 200,000 | $1,999,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 200,000 | $1,974,000 | thousands by filing date | |
| TURMERIC ACQUISITION CORP | G9127T108 | CMN | 200,000 | $1,970,000 | thousands by filing date | |
| Benitec Biopharma, Inc. | 08205P100 | common | 769,000 | $1,796,000 | thousands by filing date | |
| IMMUNEERING CORP | 45254E107 | CLASS A COM | 200,000 | $1,294,000 | thousands by filing date | |
| CANO HEALTH INC | 13781Y111 | WARR | 674,066 | $1,065,000 | thousands by filing date | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 106,000 | $995,000 | thousands by filing date | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W106 | CMN | 99,999 | $984,000 | thousands by filing date | |
| FRAZIER LIFESCIENCES ACQU CO | G3710A105 | CMN | 87,498 | $860,000 | thousands by filing date | |
| DECIBEL THERAPEUTICS INC | 24343R106 | COM | 263,600 | $801,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 34,600 | $479,000 | thousands by filing date | |
| TURMERIC ACQUISITION CORP | G9127T124 | WTS | 66,666 | $22,000 | thousands by filing date | |
| EUROPEAN BIOTECH ACQUTN CORP | G3167F128 | *W EXP 03/06/202 | 100,000 | $20,000 | thousands by filing date | |
| FRAZIER LIFESCIENCES ACQU CO | G3710A113 | WTS | 29,166 | $7,000 | thousands by filing date | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W122 | *W EXP 10/23/202 | 33,333 | $6,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-22-001372 | this filing | 2022-05-16 | acceptance time not in the bulk data set |